UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HLA-independent T cell receptors for targeting tumors with low antigen density

Nature medicine, 2022-02, Vol.28 (2), p.345-352

2022

Volltextzugriff (PDF)

CAR T cell design: approaching the elusive AND-gate

Cell research, 2023-10, Vol.33 (10), p.739-740

2023

Volltextzugriff (PDF)

Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency

Nature medicine, 2019-03, Vol.25 (3), p.530-530

2019

Volltextzugriff (PDF)

TWEAK/Fn14 Interactions Are Instrumental in the Pathogenesis of Nephritis in the Chronic Graft-versus-Host Model of Systemic Lupus erythematosus

The Journal of immunology (1950), 2007-12, Vol.179 (11), p.7949-7958

2007

Volltextzugriff (PDF)

Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency

Nature medicine, 2019-01, Vol.25 (1), p.82-88

2019

Volltextzugriff (PDF)

132 HLA-independent T cell receptors effectively target low abundance antigens

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A142-A142

2021

Volltextzugriff (PDF)

TET2 guards against unchecked BATF3-induced CAR T cell expansion

Nature (London), 2023-03, Vol.615 (7951), p.315-322

2023

Volltextzugriff (PDF)

Structural determinants of the BRCA1 : estrogen receptor interaction

Oncogene, 2005-03, Vol.24 (11), p.1831-1846

2005

Volltextzugriff (PDF)

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

Nature (London), 2019-04, Vol.568 (7750), p.112-116

2019

Volltextzugriff (PDF)

Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells

Cancer cell, 2015-10, Vol.28 (4), p.415-428

2015

Volltextzugriff (PDF)

Abstract LB153: Emergence of a hyper-proliferative phenotype in TET2 edited human CAR T cells

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.LB153-LB153

2021

Volltextzugriff (PDF)

Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function

Cancer discovery, 2024-01, Vol.14 (1), p.142-157

2024

Volltextzugriff (PDF)

BATF3/MYC axis drives hyper-proliferation of TET2 deficient CAR T cells

The Journal of immunology (1950), 2021-05, Vol.206 (1_Supplement), p.58-58.02

2021

Volltextzugriff (PDF)

Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I

Immunity (Cambridge, Mass.), 2016-08, Vol.45 (2), p.280-291

2016

Volltextzugriff (PDF)

SUV39H1 disruption imparts functional persistence to CD28-costimulated human CAR T cells

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.122-122.05

2022

Volltextzugriff (PDF)

Loss of TET2 Uncouples Proliferative and Effector Functions in CAR T Cells

Blood, 2020-11, Vol.136 (Supplement 1), p.1-1

2020

Volltextzugriff (PDF)

Ectopic activation of the miR-200c-EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy

Science translational medicine, 2021-09, Vol.13 (611), p.eabg4328

2021

Volltextzugriff (PDF)

NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand

The Journal of immunology (1950), 2013-05, Vol.190 (9), p.4650-4660

2013

Volltextzugriff (PDF)

Calibrated CAR Activation Potential Directs Alternative T Cell Fates and Therapeutic Potency

Blood, 2018-11, Vol.132 (Supplement 1), p.1412-1412

2018

Volltextzugriff (PDF)

Human natural killer cell education is dynamically controlled by environmental and cell-intrinsic HLA

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.202-202.6

2016

Volltextzugriff (PDF)

Graded potency of chimeric antigen receptor (CAR)-engineered T cells for cancer immunotherapy

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.3022-3022

2014

Volltextzugriff (PDF)

Abstract 5583: SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5583-5583

2022

Volltextzugriff (PDF)

207. Optimal Activation of Both CD28 and 4-1BB in CAR-Targeted T Cells Results in Enhanced Tumor Eradication

Molecular therapy, 2015-05, Vol.23, p.S82-S82

2015

Volltextzugriff (PDF)

4-1BBL costimulation enables CD4 T cells expressing a CD28/zeta chimeric antigen receptor to eliminate aggressive leukemia. (P4338)

The Journal of immunology (1950), 2013-05, Vol.190 (1_Supplement), p.177-177.2

2013

Volltextzugriff (PDF)

The Lytic Potential of Human Liver NK Cells Is Restricted by Their Limited Expression of Inhibitory Killer Ig-Like Receptors

The Journal of immunology (1950), 2009-08, Vol.183 (3), p.1789-1796

2009

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

HLA-independent T cell receptors for targeting tumors with low antigen density

CAR T cell design: approaching the elusive AND-gate

Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency

TWEAK/Fn14 Interactions Are Instrumental in the Pathogenesis of Nephritis in the Chronic Graft-versus-Host Model of Systemic Lupus erythematosus

Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency

132 HLA-independent T cell receptors effectively target low abundance antigens

TET2 guards against unchecked BATF3-induced CAR T cell expansion

Structural determinants of the BRCA1 : estrogen receptor interaction

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells

Abstract LB153: Emergence of a hyper-proliferative phenotype in TET2 edited human CAR T cells

Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function

BATF3/MYC axis drives hyper-proliferation of TET2 deficient CAR T cells

Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I

SUV39H1 disruption imparts functional persistence to CD28-costimulated human CAR T cells

Loss of TET2 Uncouples Proliferative and Effector Functions in CAR T Cells

Ectopic activation of the miR-200c-EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy

NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand

Calibrated CAR Activation Potential Directs Alternative T Cell Fates and Therapeutic Potency

Human natural killer cell education is dynamically controlled by environmental and cell-intrinsic HLA

Graded potency of chimeric antigen receptor (CAR)-engineered T cells for cancer immunotherapy

Abstract 5583: SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells

207. Optimal Activation of Both CD28 and 4-1BB in CAR-Targeted T Cells Results in Enhanced Tumor Eradication

4-1BBL costimulation enables CD4 T cells expressing a CD28/zeta chimeric antigen receptor to eliminate aggressive leukemia. (P4338)

The Lytic Potential of Human Liver NK Cells Is Restricted by Their Limited Expression of Inhibitory Killer Ig-Like Receptors

Suchergebnisse filtern